Barclays analyst Rajesh Patki downgraded Fluidra (FLUIF) to Equal Weight from Overweight with a price target of EUR 20, down from EUR 30. The firm says the company’s high inventory levels in U.S. distribution channels raise destocking concerns over the next few quarters. It sees the concerns leading to a better entry point for the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FLUIF:
- Fluidra price target lowered to EUR 25 from EUR 27 at JPMorgan
- Fluidra Posts Preliminary 1Q 2026 Figures and Flags Risks Around Performance Measures
- Fluidra Delivers Solid Q1 2026 and Sticks to Guidance Amid Expansion Drive
- Fluidra Shareholders Approve 2025 Accounts and Two-Part Dividend Payout
- Fluidra refreshes board committees after shareholder meeting, balancing independent and proprietary oversight